Summary

Temperature-controlled Packaging for Pharmaceutical Market Research Report Information by Product (Shippers and Containers), by Type (Active System and Passive System), by Temperature Range (-20°C and Below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and Above 25°C), by Payload Capacity (Up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and Above 150 L), by Use (Single Use and Reusable), Medicine Type (Temperature Sensitive Pharmaceutical Drugs, Vaccine, and Regenerative Medicine), by End-use Industry (Pharmaceuticals and Clinical Trails), and by Region (North America, Europe, Asia Pacific, and Rest of the World) –Market Forecast Till 2030

Market Overview
The global temperature-controlled packaging for pharmaceutical industry is expected to develop at a compound annual growth rate (CAGR) of 9.2% over the forecast period.
The Temperature-controlled Packaging for Pharmaceutical Market is driven by growth in the pharmaceutical industry, adoption of smarter cold chain technologies, and various government programs to develop regional pharmaceutical industries.

The rising demand for pharmaceutical packaging has supported the expansion of temperature-controlled packaging in the pharmaceutical business. The purpose of temperature-controlled pharmaceutical packaging is to keep sensitive products at the right temperature. Such packaging solutions are largely utilized in the healthcare industry to transport and store temperature-sensitive items under regulated conditions.

Market Segment insights
Temperature-controlled packaging for the pharmaceutical market is divided into two categories: shippers and containers.
The market is divided into two types: active systems and passive systems.
Temperature-controlled packaging for the pharmaceutical market is classified into five categories: -20°C and below, -20°C to 0°C, 2°C to 8°C, 8°C to 25°C, and beyond 25°C.
The Market is divided into five categories based on payload capacity: up to 10 L, 10 L - 20 L, 20 L - 40 L, 40 L - 150 L, and more than 150 L.
Temperature-controlled packaging for the pharmaceutical market is divided into two types: single-use and reusable.
Temperature-controlled Packaging for Pharmaceutical Market is divided into three segments based on medicine type: Temperature Sensitive Pharmaceutical Drugs, Vaccines, and Regenerative Medicine.
The market is divided into two segments based on the end use industry: pharmaceuticals and clinical trials.

Regional insights

North America held the greatest market share in 2023 and is predicted to have the highest CAGR during the forecast period. Because of the variety of lifestyle problems, the large number of patients, and the high discretionary income levels, North America is expected to be a very profitable market during the projection period. Pharmaceutical product safety requirements, as well as an increasing geriatric population, may drive up regional market demand. The market could profit from bilateral trade agreements and greater international trade.

Asia Pacific represented the second-largest share of the worldwide temperature-controlled pharmaceutical packaging market, and it is expected to grow at a revenue-based CAGR over the projected period. Because of the increase in infectious diseases and the need for cold chain solutions to protect vaccines, APAC is expected to be extremely profitable. Leading businesses in the Temperature-controlled Packaging for Pharmaceutical Market can maximize their financial profits by focusing on highly promising Asian markets.

The European Union (EU) authorities imposed a storm of new pharmaceutical packaging restrictions on counterfeit medications in 2017, and Europe is expected to develop significantly during the projected period. EU authorities have used anti-counterfeiting technologies such as overt, covert, and forensic technology for pharmaceutical packaging, prompting pharmaceutical packaging companies in the region to develop new packaging methods and procedures.

The Rest of the World consists of the Middle East, Africa, and South America. The Middle East and Africa market is predicted to expand rapidly due to rising per capita disposable income, increased healthcare awareness, and increased pharmaceutical and medicine consumption.

Major Players

Sonoco Thermosafe, UNITED PARCEL SERVICE AMERICA, INC, Kaneka Corporation, DHL International GmbH, Deutsche Bahn AG, Cold Chain Technologies, LLC, EMBALL'ISO, Inmark, LLC, Kuehne + Nagel Inc., CSafe Globalva-Q-tec AG, and a few others are among the key players in the Temperature-controlled Packaging for Pharmaceutical Market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. EXECUTIVE’S HANDBOOK
1.1. THE TOP PERFORMING SEGMENTS
1.2. KEY TRENDS SUMMARIZED
1.3. PRICING OUTLOOK
1.4. STRATEGIC INSIGHTS
1.5. WHO ARE THE KEY PLAYERS IN THE MARKET?
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. REPORT SEGMENTATION & SCOPE
2.3. REGIONAL & COUNTRY LEVEL COVERAGE
2.4. WHY YOU NEED THIS REPORT?
3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA FLOW
3.2.1. DATA MINING PROCESS
3.3. PURCHASED DATABASE:
3.4. SECONDARY SOURCES:
3.4.1. SECONDARY RESEARCH DATA FLOW:
3.5. PRIMARY RESEARCH:
3.5.1. PRIMARY RESEARCH DATA FLOW:
3.5.2. PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.5.3. PRIMARY RESEARCH: REGIONAL COVERAGE
3.6. APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1. REVENUE ANALYSIS APPROACH
3.7. DATA FORECASTING
3.7.1. DATA FORECASTING TECHNIQUE
3.8. DATA MODELING
3.8.1. MICROECONOMIC FACTOR ANALYSIS:
3.8.2. DATA MODELING:
3.9. TEAMS AND ANALYST CONTRIBUTION
SECTION III: QUALITATIVE ANALYSIS
4. MARKET DYNAMICS
4.1. INTRODUCTION
4.2. GROWTH PARAMETERS MAPPED - DRIVERS
4.2.1. GROWTH IN THE PHARMACEUTICAL INDUSTRY SUPPLEMENTING SALES TO THE SIGNIFICANT EXTENT
4.2.2. ADOPTION OF SMARTER COLD CHAIN TECHNOLOGY
4.3. WHAT ARE THE CHALLENGES FACED BY INDUSTRY PARTICIPANTS?
4.3.1. RISE IN RAW MATERIAL COSTS
4.4. OPPORTUNITIES
4.4.1. VARIOUS GOVERNMENT INITIATIVES ARE CARRIED OUT BY VARIOUS COUNTRIES TO BOOST THE PHARMACEUTICAL INDUSTRY.
4.5. IMPACT ANALYSIS OF COVID-19
4.5.1 ECONOMIC IMPACT
4.5.1.1 IMPACT ON THE PACKAGING INDUSTRY
4.5.2 IMPACT ON PRODUCTION
4.5.3 IMPACT ON TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY
4.5.3.1 IMPACT ON SUPPLY CHAIN
4.5.3.2 IMPACT ON RAW MATERIALS
4.5.3.3 CASH FLOW CONSTRAINTS
4.5.1. IMPACT ON WORLD TRADE
5. MARKET FACTOR ANALYSIS
5.1. SUPPLY/VALUE CHAIN ANALYSIS
5.1.1. PARTICIPANTS
5.1.2. VALUE PERCOLATION ACROSS THE CHAIN
5.1.3. INTEGRATION LEVELS
5.1.4. KEY ISSUES ADDRESSED
5.2. PORTER’S FIVE FORCES MODEL
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
SECTION IV: QUANTITATIVE ANALYSIS
6. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT
6.1. INTRODUCTION
6.2. SHIPPERS
6.3. CONTAINERS
7. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE
7.1. AUTOMOTIVE
7.2. ACTIVE SYSTEM
7.3. PASSIVE SYSTEM
8. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE
8.1. INTRODUCTION
8.2. -20°C AND BELOW
8.3. -20°C TO 0°C
8.4. 2°C TO 8°C
8.5. 8°C TO 25°C
8.6. ABOVE 25°C
9. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY
9.1. INTRODUCTION
9.2. UP TO 10 L
9.3. 10 L - 20 L
9.4. 20 L - 40 L
9.5. 40 L - 150 L
9.6. ABOVE 150 L
10. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE
10.1. INTRODUCTION
10.2. SINGLE USE
10.3. REUSABLE
11. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE
11.1. INTRODUCTION
11.2. TEMPERATURE SENSITIVE PHARMACEUTICAL DRUGS
11.3. VACCINE
11.4. REGENERATIVE MEDICINE
12. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END-USE INDUSTRY
12.1. INTRODUCTION
12.2. PHARMACEUTICALS
12.3. CLINICAL TRAILS
13. GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION
13.1. INTRODUCTION
13.2. NORTH AMERICA
13.2.1. U.S.
13.2.2. CANADA
13.3. EUROPE
13.3.1. GERMANY
13.3.2. FRANCE
13.3.3. U.K.
13.3.4. ITALY
13.3.5. SPAIN
13.3.6. REST OF EUROPE
13.4. ASIA PACIFIC
13.4.1. CHINA
13.4.2. JAPAN
13.4.3. INDIA
13.4.4. SOUTH KOREA
13.4.5. TAIWAN
13.4.6. PHILIPPINES
13.4.7. INDONESIA
13.4.8. THAILAND
13.4.9. MALAYSIA
13.4.10. SINGAPORE
13.4.11. HONG KONG
13.4.12. AUSTRALIA
13.4.13. REST OF ASIA-PACIFIC
13.5. REST OF THE WORLD
13.5.1. MIDDLE EAST & AFRICA
13.5.2. SOUTH AMERICA
SECTION V: COMPETITIVE ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. INTRODUCTION
14.2. COMPETITION DASHBOARD
14.3. COMPANY MARKET SHARE ANALYSIS, 2023
14.4. WHO ARE THE MARKET DISRUPTORS & INNOVATORS?
14.5. WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS?
14.6. THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MARKET
14.7. COMPETITIVE BENCHMARKING
14.8. PUBLIC PLAYERS STOCK SUMMARY
14.9. COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
14.10. KEY DEVELOPMENTS & GROWTH STRATEGIES
14.10.1. PRODUCT DEVELOPMENTS
14.10.2. MERGER & ACQUISITION
14.10.3. EXPANSION
15. COMPANY PROFILES
15.1. COLD CHAIN TECHNOLOGIES, LLC
15.1.1. COMPANY OVERVIEW
15.1.2. FINANCIAL OVERVIEW
15.1.3. PRODUCT OFFERED
15.1.4. KEY DEVELOPMENTS
15.1.5. SWOT ANALYSIS
15.1.6. KEY STRATEGIES
15.2. EMBALL’ISO
15.2.1. COMPANY OVERVIEW
15.2.2. FINANCIAL OVERVIEW
15.2.3. PRODUCT OFFERED
15.2.4. KEY DEVELOPMENTS
15.2.5. SWOT ANALYSIS
15.2.6. KEY STRATEGIES
15.3. INMARK, LLC
15.3.1. COMPANY OVERVIEW
15.3.2. FINANCIAL OVERVIEW
15.3.3. PRODUCT OFFERED
15.3.4. KEY DEVELOPMENTS
15.3.5. SWOT ANALYSIS
15.3.6. KEY STRATEGIES
15.4. SONOCO THERMOSAFE
15.4.1. COMPANY OVERVIEW
15.4.2. FINANCIAL OVERVIEW
15.4.3. PRODUCT OFFERED
15.4.4. KEY DEVELOPMENTS
15.4.5. SWOT ANALYSIS
15.4.6. KEY STRATEGIES
15.5. VA-Q-TEC AG
15.5.1. COMPANY OVERVIEW
15.5.2. FINANCIAL OVERVIEW
15.5.3. PRODUCT OFFERED
15.5.4. KEY DEVELOPMENTS
15.5.5. SWOT ANALYSIS
15.5.6. KEY STRATEGIES
15.6. DEUTSCHE BAHN AG
15.6.1. COMPANY OVERVIEW
15.6.2. FINANCIAL OVERVIEW
15.6.3. PRODUCT OFFERED
15.6.4. KEY DEVELOPMENTS
15.6.5. SWOT ANALYSIS
15.6.6. KEY STRATEGIES
15.7. DHL INTERNATIONAL GMBH
15.7.1. COMPANY OVERVIEW
15.7.2. FINANCIAL OVERVIEW
15.7.3. PRODUCT OFFERED
15.7.4. KEY DEVELOPMENTS
15.7.5. SWOT ANALYSIS
15.7.6. KEY STRATEGIES
15.8. KUEHNE + NAGEL INC.
15.8.1. COMPANY OVERVIEW
15.8.2. FINANCIAL OVERVIEW
15.8.3. PRODUCT OFFERED
15.8.4. KEY DEVELOPMENTS
15.8.5. SWOT ANALYSIS
15.8.6. KEY STRATEGIES
15.9. UNITED PARCEL SERVICE OF AMERICA, INC.
15.9.1. COMPANY OVERVIEW
15.9.2. FINANCIAL OVERVIEW
15.9.3. PRODUCT OFFERED
15.9.4. KEY DEVELOPMENTS
15.9.5. SWOT ANALYSIS
15.9.6. KEY STRATEGIES
15.10. KANEKA CORPORATION
15.10.1. COMPANY OVERVIEW
15.10.2. FINANCIAL OVERVIEW
15.10.3. PRODUCT OFFERED
15.10.4. KEY DEVELOPMENTS
15.10.5. SWOT ANALYSIS
15.10.6. KEY STRATEGIES
15.11. CSAFE GLOBAL
15.11.1. COMPANY OVERVIEW
15.11.2. FINANCIAL OVERVIEW
15.11.3. PRODUCT OFFERED
15.11.4. KEY DEVELOPMENTS
15.11.5. SWOT ANALYSIS
15.11.6. KEY STRATEGIES
16. RECOMMENDATIONS & EXPERT INSIGHTS
16.1. WHAT IS THE SHORT-TERM VS LONG-TERM OUTLOOK FOR MARKET?
16.2. WHO ARE THE PLAYERS TO LOOK OUT FOR?
16.3. WHAT WILL THE PRODUCT MIX LOOK IN COMING YEARS?
17. MRFR OFFERINGS & TEAM
17.1. CITATIONS & MEDIA
17.2. OUR REGIONAL REPRESENTATIVES
17.3. RELATED REPORTS
17.4. OUR DOMAIN COVERAGE